Next Article in Journal
Identification of Malignancies from Free-Text Histopathology Reports Using a Multi-Model Supervised Machine Learning Approach
Previous Article in Journal
Popularity Prediction of Instagram Posts
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Role of Artificial Intelligence, MLR and Statistical Analysis in Investigations about the Correlation of Swab Tests and Stress on Health Care Systems by COVID-19

1
Department of Computer Engineering, Modelling, Electronics and Systems Engineering, University of Calabria, 87036 Rende, Italy
2
Department of DAMS, University of Calabria, 87036 Rende, Italy
3
Centro Internacional de Física, Bogotá 111321, Colombia
4
Department of Physics, University of Calabria, 87036 Rende, Italy
5
Department of Mechanical, Energy and Management Engineering, University of Calabria, 87036 Rende, Italy
*
Author to whom correspondence should be addressed.
Submission received: 27 August 2020 / Revised: 18 September 2020 / Accepted: 19 September 2020 / Published: 21 September 2020

Abstract

:
The outbreak of the new Coronavirus (COVID-19) pandemic has prompted investigations on various aspects. This research aims to study the possible correlation between the numbers of swab tests and the trend of confirmed cases of infection, while paying particular attention to the sickness level. The study is carried out in relation to the Italian case, but the result is of more general importance, particularly for countries with limited ICU (intensive care units) availability. The statistical analysis showed that, by increasing the number of tests, the trend of home isolation cases was positive. However, the trend of mild cases admitted to hospitals, intensive case cases, and daily deaths were all negative. The result of the statistical analysis provided the basis for an AI study by ANN. In addition, the results were validated using a multivariate linear regression (MLR) approach. Our main result was to identify a significant statistical effect of a reduction of pressure on the health care system due to an increase in tests. The relevance of this result is not confined to the COVID-19 outbreak, because the high demand of hospitalizations and ICU treatments due to this pandemic has an indirect effect on the possibility of guaranteeing an adequate treatment for other high-fatality diseases, such as, e.g., cardiological and oncological ones. Our results show that swab testing may play a significant role in decreasing stress on the health system. Therefore, this case study is relevant, in particular, for plans to control the pandemic in countries with a limited capacity for admissions to ICU units.

1. Introduction

The COVID-19 pandemic disease has been extensively studied, in view of several different aspects. Virologic studies [1] have investigated the virus genome, proving its natural origin and studying its mutations. Sociological and economic studies have considered changes in lifestyle and economic and sustainable development effects [2,3,4,5] in correlation with nonpharmacological actions aimed to control the pandemic spread, such as lockdown [6,7], border closure, and social distancing. Other studies focused on the mechanisms and times of incubation [8], resistance, dynamics of transmission [9,10,11], environmental factors, and conditions like the role of UV and the climate [12,13,14,15]. A large number of studies have been dedicated to statistical assessment methods and modeling of the outbreak, usually considering the number of positive cases [16,17,18,19], active cases, or the deaths and intensive care hospitalizations [20,21], as well as health risks [22,23]. Besides, the sociotechnical framework governing the effects of human behavior and technical factors is another critical subject in analyzing a new phenomenon such as COVID-19 [24,25].
A problem that has been an object of much attention is the identification of infected people. It covers two different aspects, namely the physical identification of infected and contagious asymptomatic people and the identification of people who have been infected and are expected to no longer be susceptible to infection. Swab testing is the usual procedure to experimentally assess the former one, which could otherwise only be inferred through statistical studies [16]. In Italy, an acceleration of the use of swab tests happened after about two months (although it should be noted that one-third of the tests were applied to people who had already been tested at least once), and the results of this were a significant reduction of active cases [26].
The use of swab testing is growing in many countries in order to fight the increasing rate of the pandemic [27,28]. One element that is relevant for this purpose is the criterion and aim that is used to decide whether to apply the test and to whom it applies. Besides being a verification of recovery, this testing may be used to detect infected people. In this case, a test of random samples is opportune [17] or can be used for the early identification of mildly infected people, which, to some extent, dominated in Italy. A broad literature exists about the possibility that these tests provide a wrong answer. Gray et al. (2020) discussed the impact of this and concluded that no test would be better than a wrong test [29]. In this context, it must be observed that there is an important statistical difference between wrong positive and wrong negative tests [30]. Eberhardt et al. (2020) analyzed a multistage group testing method for testing large populations and showed that such a method would be more efficient than individual testing [31]. George and Wang (2020) analyzed the variations in the testing and reporting of confirmed cases of COVID-19. Their results showed the advantages of accurate-scale mass and systematic tests [32]. Corman et al. (2020) determined how tests could affect the treatment and benefits of mild case detection [33], and to some extent, our study goes in the same direction.
These studies show the importance and interplay, in COVID-19 investigations, of several variables, including swab testing. This research studies the statistical correlation between the number of swab tests and the trends of daily positive cases, mild cases admitted to hospitals, intensive care cases, and the death rate. Therefore, the variables we selected for this analysis were “Daily new cases”, “Total home isolation”, and “Total mild hospital”. The dependent variable was the “Total intensive cases in the hospital”. The main goal of the research was to assess the role of such a systematic test in controlling the COVID-19 pandemic and reducing pressure on the health system. The result of this research allowed us to identify certain output variables for whose correlation the use of an AI approach would be convenient. A second goal of this paper was to analyze the correlation of daily new cases, home isolation, and mild cases in the hospital, with the ICU cases by using ANN-GFNs (Artificial Neural Network based on Generalized Feedforward Networks). Finally, the results of this analysis were validated using an MLR technique in order to calculate the intensive care number.

2. Materials and Methods

We use the available COVID-19 data in six Italian regions and at the national level to explore possible correlations between the increasing number of swabs (Swabs) and the trends of several variables. The selected variables include daily new cases, home isolated patients, patients admitted to a hospital but in a mild condition (Mild hosp.), patients treated in intensive care units of a hospital (Int. care hosp.), and daily deaths.
The approach of the study is based on the p-value, Beta coefficient, and t-test. First, to analyze the possible impact of daily swabs on the other variables, the datasets were divided into two periods. The statistical analysis was done for each group, and the results of the two analyses were compared with each other. For each case study, in order to select the day on which to split the whole period into two periods, we first calculated the total average number of daily swabs and then looked for the date when the number of daily swabs exceeded that average value for three consecutive days. That date was selected for the splitting.
An appropriate tool to analyze situations with several variables and to monitor performance is provided by AI [34,35]. Therefore, as the next step, Machine Learning through ANN (Artificial Neural Network) was used to investigate, by Artificial Intelligence, the correlations between the output variables of the statistical analysis. For the Machine Learning, the variables were selected based on the results of the statistical analysis, considering those that had the most significant relationship with the number of daily tests (Swab Tests). For the validation of the ANN model results, a MLR (Multivariate Linear Regression) with the same variables as the ANN model was used, and a prediction equation was provided. The flowchart of our analysis is presented in Figure 1.

2.1. Case Study

In this study, we analyzed the relevant datasets of six regions in Italy. Moreover, the analysis was also carried out for the whole of Italy. The location of the six regions is shown in Figure 2, and the details of the selected case studies are presented in Table 1.
Our analysis covered the period from the beginning of March to the end of April. The outbreak in four out of the six regions, namely Lombardy, Piedmont, Emilia–Romagna, and Veneto, was more substantial. The regions of Campania and Sicily were selected because of their high population.

2.2. Mathematical Modeling and Statistical Analysis

Mathematical modeling and statistical analysis are widely used in various fields, e.g., natural and human hazards [41,42,43,44,45], and for many phenomena, including hazards and optimization [46,47,48]. Thus, it is essential to express the problem in the form of an equation or a model [49,50,51,52,53,54,55]. Due to the complexity of the natural phenomena, several criteria can be used to obtain the best mathematical modeling for a given problem [56,57,58,59,60,61].
Our purpose is to study the effect of an independent variable on one or more dependent variables and to assess the possible existence of a relationship between them. An efficient statistical technique to achieve this is to evaluate a coefficient, the beta coefficient, which measures the degree of change in a dependent variable (outcome variable) in correspondence with a 1-unit change in the independent variable (predictor variable). Of course, the beta coefficient value can be negative or positive. This quantitative evaluation only makes sense if the possible existence of a significant relationship between the two variables has been previously assessed. This is established by evaluating another parameter, the p-value, whose value, if smaller than 0.05 (or a confidence level of 95%), indicates the existence of a significant correlation between the considered variables [62].

The Set-Up of the SPSS Model

To carry out our statistical analyses, the SPSS model has been used to study the following variables:
  • Number of daily tests (Swabs test);
  • Number of patients isolated at home (Home isolation);
  • Number of patients admitted to the hospital in mild condition (Mild hosp.);
  • Number of patients admitted to the intensive care section of the hospital (Int. care hosp.);
  • Number of daily deaths;
The analysis method proceeded as discussed in the previous section.
  • Use of the Independent-Samples t-test: The Independent-Samples t-test is used to test the existence of significant differences (with a confidence level of 95%) between the averages of two datasets. We recall that our dataset was divided into two subsets based on comparing the daily number of tests with its average over the full period. The t-test was applied both to the independent variable (Swabs) and to the dependent variables (Home isolation, Mild hosp., Int. care hosp., daily deaths, and daily new cases) to determine whether the comparison between the two periods of the corresponding data presented a significant difference.
  • Evaluation of the p-value: If the result of the p-value resulting from the comparison of the independent variable (Swabs) and each dependent variable (Home isolation, Mild hosp., Int. care hosp.) was less than 0.05, the relationship between the two variables was considered to be significant, and we proceeded to the calculation of the beta coefficient. If, instead, the p-value was larger than 0.05, the significance of the relationship was excluded.
  • Evaluation of the beta coefficient: A positive (negative) value of this coefficient meant that, for every 1-unit increase (decrease) in the predictor variable (swab number in our case), the outcome variable increased (decreased) by an amount equal to the value of the beta coefficient.

3. Results

3.1. Correlations between Swabs and the Other Variables in the Whole of Italy

Our first analysis referred to the global country dataset. The results of the correlations between the swab number and the output variables in the two periods are presented in Table 2 and Table 3. The daily variations of the different parameters in Italy are presented in Figure 3 and Figure 4.
As shown in Table 2, in Italy, the average number of the independent variable (swabs) increased significantly by 3.12 times. This was compared with the variation in the same period of the outcome variables. One sees that this increase was accompanied by a significant increase in the average number of home-isolated patients (4.57 times), Mild Hosp cases (2.00 times), and Int Care Hosp cases (1.49 times). Instead, as indicated by the corresponding p-values, the increase (by a factor of 1.29) in the average number of Daily Deaths, and the decrease (by a factor of 0.98) in the average number of Daily New Cases were not significant.
As for the relationship between the daily swabs and the outcome variables, Table 3 shows that, during the first period (1 March to 31 March), it was significantly positive for each of the five variables. During the second period (1 April to 30 April), the correlation with Home isolation remained significantly positive, those with Mild hosp., Int. Care hosp., and Daily deaths became significantly negative, and that with Daily new cases, although turned negative, was not significant.

3.2. Correlations between Swabs and Other Variables at the Regional Level

The global analysis at the country level made it interesting to check whether the global trends we found were also shared at the local level in the six regions that we considered. We note that, together, these six regions account for 57.3% of the country population.
Below, we present the results of the regional analysis of the correlations between the number of swabs and those of the outcome variables in two different periods, determined through the procedure described in Section 2. Table 4 and Table 5 refer to Lombardy, Veneto, and Piedmont, for which data are available from 1 March, and Table 6 and Table 7 refer to Emilia–Romagna, Campania, and Sicily, for which the first day for which data were available was different.
To summarize the t-test results of Table 4, we can say that:
  • In the three regions, there was a remarkable increase in the average number of daily tests: in Lombardy by a factor of 2.48, in Veneto by a factor of 2.64, and in Piedmont by a factor of 3.69
Against this increase:
  • The average number of Home isolation and Mild hospital increased significantly for all of them.
  • The average number of Int Care Hosp also increased everywhere, although not significantly in Piedmont.
  • Daily New Cases exhibited a general decrease that was not significant
  • Daily Deaths decreased (not significantly) in Lombardy and significantly increased in Piedmont and Veneto.
The correlation analysis of Table 5 can be summarized as follows:
  • In the first period, in each of the three regions, the global Italian result was confirmed, and one finds a significantly positive correlation between the number of swabs and each outcome variable.
  • In the second period, whereas for Home isolation there was a positive correlation that was only significant in Lombardy, all the other correlations generally turned negative in a significant way, the only exceptions being Daily new cases in all three regions and Daily deaths in Veneto and Piedmont.
To summarize the t-test results of Table 6, we can say that:
  • In the three regions, there was a remarkable increase in the average number of daily tests: by a factor of 2.18 in Emilia–Romagna, and by a factor in the order of 3.5 in Campania and Sicily, although one may observe that, in these last two regions, the average in the first period was relatively low.
Against this increase:
  • The average number of Home isolation and Mild hosp. increased significantly for all of them.
  • The average number of Int Care Hosp also increased everywhere, but the increase was only significant in Emilia–Romagna.
  • As for Daily New Cases, no significant variation was observed in Campania, which differed from Emilia–Romagna and Sicily, where there was a significant decrease.
  • The variations in Daily Deaths were not significant.
The correlation analysis of Table 7 can be summarized as follows:
  • In the first period, in each region, the global Italian result was confirmed, with a significantly positive correlation between the number of swabs and each outcome variable. Sicily, to some extent, is the only partial exception, since the relationship for Int. Care Hosp, although positive, did not reach a significant level.
  • In the second period, there was a general turn from a positive to a negative relationship in Emilia–Romagna, but without arriving at a significant level. In Campania, Home isolation was positively, but not significantly, correlated, whereas all the other variables exhibited a significantly negative correlation. In Sicily, we found two significant correlations (Home isolation, positive; and Int. Care Hosp, negative) and no significant relationship for the remaining three variables.

3.3. The Model Using ANN

As the results of Table 2 show, the number of Total home isolation, Total mild hospital, and Intensive care in the hospital changed significantly with the number of swabs, whereas for Daily new cases, this only happened for the first period. Therefore, the variables we selected for the AI analysis were Daily new cases, Total home isolation, and Total mild hospital. The dependent variable was the Total intensive cases in the hospital.
In this section, we shall investigate this possible correlation using the ANN method in order to analyze the Intensive care number. The selected ANN technique is based on Generalized Feedforward Networks (GFNs). GFNs are a generalization of the Multi-Layer Perceptrons (MLPs), so that connections can be over one or more layers [63,64]. In theory, MLP models can analyze an algorithm that GFN models can solve, but, in practice, GFNs are much more efficient in exploring such a connection due to the smaller number of training epochs required by the algorithm [65]. There are no specific rules for defining the control parameters, and they are mostly based on the results of previous studies and experts’ opinions [66,67]. In this study, the selected control parameters were:
  • The selected hidden layers of ANN for the analysis: considered as 1, 3, 5, 10, 15, and 20;
  • The maximum iteration values: considered as 20, 40, 70, 100, 120, and 140;
  • The mean squared error (MSE) for the evaluation of the performance;
  • The training data was 70% of the dataset, and the rest was for validation (15%) and testing (15%).
After an initial analysis based on the control parameters and trial and error, the best developed ANN model was constructed. The structure and details of the model are shown in Table 8.
The obtained result of the best cost in each iteration is shown in Figure 5. The best cost in each iteration shows the performance function of the algorithm, and it depends on the values of error in each iteration. According to Figure 5, after about 35 iterations with 0.002, the best cost was reached, and the model achieved convergence.
The ANN model first needs to be trained and validated. The results of the training, validation, and testing of the ANN algorithm are presented in Table 9. The comparison between the predicted values and the real data in the testing stage is displayed in Figure 6. Extra details about the model are presented in Appendix A.
The impact of each variable on the Intensive cases in the hospital, based on the training dataset, is shown in Figure 7. According to Figure 7, the dominance of the role of Mild hospital over Home isolation, in terms of the impact on the number of Intensive care hospital, is evident (Similar results were achieved for the testing dataset and validation dataset, as presented in Appendix A).
The results and the predicted values by the developed ANN model show that AI is a powerful tool for the study of our problem, as confirmed by the value of the final R2, and they confirm the results of the statistical analysis of the swab-output variables correlations.

4. Discussion

In this section, we summarize the results of the previous section. The first part of our statistical analysis was based on the t-test. In Italy, during the period we analyzed (March–April), there was a significant change in the number of swab tests. At the country level, one can say that there was a first period (March) with a country average of about 15,000 tests per day and that this average grew more than three times in the following month. Analogous increases in the number of tests were observed at the regional level, although they were probably also sensitive to the actual level of development of the pandemic in the specific region.
This preliminary analysis confirms that there was a significant change in the application of these tests. This supports the research hypothesis that a significant change in the number of swab tests might be reflected in the indicators that describe the level of development of the pandemic. To test this hypothesis, we carried out a statistical analysis of the possible correlation between the number of tests and contagious people, recovered ones, and deaths. At the national level, the hypothesis was confirmed, with the exception of daily new cases. These correlations are generally also observed at the regional level, although minor deviations may occur. In particular, these deviations seem to be sizeable in Emilia–Romagna and Veneto, and this may find an explanation in the improvement of the situation in these two regions during April [19]. This also happened in relation to the number of deaths. As might have been expected, we found that, with the increase of the number of tests in the second period, the correlation between the death rate and the number of swab tests diminished considerably as compared to the first period. Instead, significant correlations were generally found for the three variables that were of the utmost importance to health system stresses, relating to the total number of cases and a less advanced level of development of the sickness. The evidence was stronger in the regions where the pandemic spread more.
Of course, this discussion must take into account the multiple reasons that lead one to apply the test. This means that, in any case, only a fraction of those tests that are applied can be related to the variables we studied, but this can be estimated to only be a second-order effect.
The last part of our analysis had a different purpose. Artificial Intelligence is a powerful tool for analyzing many data in order to detect possible correlations between them. We applied the ANN technique to study one of the most critical aspects of the pandemic, the admission to ICUs. We found an excellent agreement with the observed number of ICU admissions. This aspect must not be underestimated when one considers that the stress on ICUs is probably one of the most critical factors to consider when planning a response to the pandemic [68,69].
In the specific case of Italy, when the peak shown in Figure 5 was reached, the value of ICU hospitalizations was close to the health system’s response capacity, although a 40% increase of available ICU units was planned for a couple of weeks later [70]. We recall that the Italian ICU capacity was then in the order of 120 ICUs per million inhabitants, and it must be underscored that this is a high performance when compared with different countries, as presented in Table 10.
A validation of our results on the role of swabs was provided by determining a prediction equation, which was obtained using MLR. We already pointed out the usefulness of the swabs in identifying infected people without symptoms, who would then be home-isolated. The variables for our MLR analysis were the total number of Home isolation (x1), that of mild condition admissions to a hospital (x2), and that of Daily new cases (x3). These variables were used as independent variables to determine a dependent variable, y, the total number of patients admitted in the ICUs of a hospital.
According to Equation (1), the prediction equation we obtained was:
y   =   77.751 0.020   x 1 + 0.164   x 2 + 0.38   x 3 ,   with   R 2   =   0.995
Table 11 provides the details of the analysis, and the values of the beta coefficients showed that the highest impact variable was x2, followed by the variable x1. We note that the increase in the number of home isolation cases, which we found to be correlated to swab tests, was associated with a decrease in the total number of patients admitted to hospital intensive care units.

5. Conclusions

We studied the statistic correlation between the number of applied swab tests and the most important indicators of the level of development of the COVID-19 pandemic in Italy and six Italian regions. Four regions were chosen, based on the diffusion of the pandemic, and the remaining two were chosen based on the size of their populations.
The nation-wide statistical analysis confirmed the research hypothesis that a significant change in the number of swab tests might be reflected in the indicators that describe the level of development of the pandemic. The analysis showed the advantages of increasing the number of swab tests, since, by increasing it, the trend of home isolation cases was positive. However, the trend of mild cases admitted to hospitals, intensive case cases, and daily death were all negative.
The statistical analysis was accompanied by AI techniques and validated through MLR. We applied the ANN technique to study one of the most critical aspects of the pandemic, the admission to ICUs, and the results showed an excellent agreement with the observed number of ICU admissions. The results and the predicted values by the developed ANN model show that AI is a powerful tool for studying our problem. Additionally, it confirms the results of the previous statistical analysis of swab-output variables correlations.
A validation of our results was provided by determining a prediction equation using the multivariate linear regression (MLR) approach. The results of MLR showed that the increase in the number of home isolation cases was associated with a decrease in the total number of patients admitted to hospital intensive care units. This could be correlated to an increase of swab tests, since identifying infected people (even those without symptoms, who would then be home-isolated) would lead to a decrease in new contagions.
In conclusion, swab testing may play a significant role in decreasing stress on the health system. Therefore, this case study is particularly relevant for plans to control the pandemic in countries with a limited capacity for admissions to ICU units. The relevance of these results is not confined to the COVID-19 outbreak, because the high demand for hospitalizations and ICU treatments resulting from this pandemic has an indirect effect on the possibility of guaranteeing an adequate treatment for other high-fatality diseases.
For possible future studies, it is recommended to see the impact of delays in swab test results in different countries, since the results in some countries are provided after several days, affecting proper home isolation. Besides, the use of other ANN algorithms or other machine-learning techniques may improve our results and is recommended for future studies.

Author Contributions

The author’s contributions in the paper are as follows: Conceptualization, B.P. (Behrouz Pirouz) and G.V.; methodology, B.P. (Behzad Pirouz) and H.J.N.; software, B.P. (Behzad Pirouz); validation, B.P. (Behzad Pirouz); formal analysis, B.P. (Behrouz Pirouz); investigation, B.P. (Behzad Pirouz) and H.J.N.; writing—original draft preparation, B.P. (Behrouz Pirouz); writing—review and editing, G.V.; supervision, G.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We are grateful to Luigi Grasso for an interesting discussion that stimulated this research, and to Professor Manlio Gaudioso and Dr. Agostino Gnasso for their critical reading of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Figure A1. Predicted values by ANN algorithm vs. training data set.
Figure A1. Predicted values by ANN algorithm vs. training data set.
Information 11 00454 g0a1
Figure A2. The impact of each variable on the result (Intensive case in the hospital) for testing data set.
Figure A2. The impact of each variable on the result (Intensive case in the hospital) for testing data set.
Information 11 00454 g0a2
Figure A3. Predicted values by ANN algorithm vs. cross validation data set.
Figure A3. Predicted values by ANN algorithm vs. cross validation data set.
Information 11 00454 g0a3
Figure A4. The impact of each variable on the result (Intensive case in the hospital) for cross-validation data set.
Figure A4. The impact of each variable on the result (Intensive case in the hospital) for cross-validation data set.
Information 11 00454 g0a4

References

  1. Andersen, K.G.; Rambaut, A.; Lipkin, W.I.; Holmes, E.C.; Garry, R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020, 26, 450–452. [Google Scholar] [CrossRef] [Green Version]
  2. Pirouz, B.; Arcuri, N.; Pirouz, B.; Palermo, S.A.; Turco, M.; Maiolo, M. Development of an assessment method for evaluation of sustainable factories. Sustainability 2020, 12, 1841. [Google Scholar] [CrossRef] [Green Version]
  3. Pirouz, B.; Arcuri, N.; Maiolo, M.; Talarico, V.C.; Piro, P. A new multi-objective dynamic model to close the gaps in sustainable development of industrial sector. IOP Conf. Ser. Earth Environ. Sci. 2020, 410, 012074. [Google Scholar] [CrossRef] [Green Version]
  4. Maiolo, M.; Pirouz, B.; Bruno, R.; Palermo, S.A.; Arcuri, N.; Piro, P. The role of the extensive green roofs on decreasing building energy consumption in the mediterranean climate. Sustainability 2020, 12, 359. [Google Scholar] [CrossRef] [Green Version]
  5. Pirouz, B.; Maiolo, M. The role of power consumption and type of air conditioner in direct and indirect water consumption. J. Sustain. Dev. Energy Water Environ. Syst. 2018. [Google Scholar] [CrossRef] [Green Version]
  6. Shen, M.; Peng, Z.; Guo, Y.; Xiao, Y.; Zhang, L. Lockdown may partially halt the spread of 2019 novel coronavirus in Hubei province, China. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
  7. Chinazzi, M.; Davis, J.T.; Ajelli, M.; Gioannini, C.; Litvinova, M.; Merler, S.; Piontti, A.P.; Mu, K.; Rossi, L.; Sun, K.; et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science 2020, 368, 395–400. [Google Scholar] [CrossRef] [Green Version]
  8. Worldometer Coronavirus Incubation Period. Available online: https://www.reuters.com/article/us-china-health-incubation/coronavirus-incubation-could-be-as-long-as-27-days-chinese-provincial-government-says-idUSKCN20G06W (accessed on 26 April 2020).
  9. Kampf, G.; Todt, D.; Pfaender, S.; Steinmann, E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect. 2020, 104, 246–251. [Google Scholar] [CrossRef] [Green Version]
  10. Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.M.; Lau, E.H.Y.; Wong, J.Y.; et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 2020. [CrossRef]
  11. Phan, L.T.; Nguyen, T.V.; Luong, Q.C.; Nguyen, T.V.; Nguyen, H.T.; Le, H.Q.; Nguyen, T.T.; Cao, T.M.; Pham, Q.D. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N. Engl. J. Med. 2020, 382, 1199–1207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Pirouz, B.; Golmohammadi, A.; Masouleh, H.S.; Violini, G.; Pirouz, B. Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
  13. Grant, W.B.; Giovannucci, E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States. Dermato-Endocrinology 2009, 1, 215–219. [Google Scholar] [CrossRef]
  14. Pirouz, B.; Haghshenas, S.S.; Haghshenas, S.S.; Piro, P. Investigating a serious challenge in the sustainable development process: Analysis of confirmed cases of COVID-19 (new type of Coronavirus) through a binary classification using artificial intelligence and regression analysis. Sustainability 2020, 12, 2427. [Google Scholar] [CrossRef] [Green Version]
  15. Haghshenas, S.S.; Pirouz, B.; Haghshenas, S.S.; Pirouz, B.; Piro, P.; Na, K.S.; Cho, S.E.; Geem, Z.W. Prioritizing and analyzing the role of climate and urban parameters in the confirmed cases of COVID-19 based on artificial intelligence applications. Int. J. Environ. Res. Public Health 2020, 17, 3730. [Google Scholar] [CrossRef]
  16. Chen, Y.C.; Lu, P.E.; Chang, C. A Time-dependent SIR model for COVID-19. arXiv 2020, arXiv:2003.00122. [Google Scholar]
  17. Pirouz, B.; Violini, G. A Novel Approach to Evaluate the Asymptomatic COVID19 Contagions. 2020. Available online: https://www.asiabiotech.com/exclusive/2020-04-30-03.pdf (accessed on 21 September 2020). [CrossRef]
  18. Hu, Z.; Ge, Q.; Jin, L.; Xiong, M. Artificial intelligence forecasting of covid-19 in China. arXiv 2020, arXiv:2002.07112. [Google Scholar]
  19. Pirouz, B.; Haghshenas, S.S.; Pirouz, B.; Haghshenas, S.S.; Piro, P. Development of an assessment method for investigating the impact of climate and urban parameters in confirmed cases of COVID-19: A new challenge in sustainable development. Int. J. Environ. Res. Public Health 2020. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Violini, G. Differenze Nazionali e Regionali Riguardo il COVID-19. PUCMM Preprint 2020. [Google Scholar] [CrossRef]
  21. Violini, G. Does COVID-19 Have an Internal Clock? Or is Pandemic Development Anthropic. CIF Preprint 2020. [Google Scholar] [CrossRef]
  22. Wen, J.; Aston, J.; Liu, X.; Ying, T. Effects of misleading media coverage on public health crisis: A case of the 2019 novel coronavirus outbreak in China. Anatolia 2020, 31, 331–336. [Google Scholar] [CrossRef]
  23. Nkengasong, J.N.; Mankoula, W. Looming threat of COVID-19 infection in Africa: Act collectively, and fast. Lancet 2020, 395, 10227. [Google Scholar] [CrossRef] [Green Version]
  24. Shin, D.; Ibahrine, M. The socio-technical assemblages of blockchain system: How blockchains are framed and how the framing reflects societal contexts. Digit. Policy Regul. Gov. 2020. [Google Scholar] [CrossRef]
  25. Shin, D.D.; Beede, P.; Ibahrine, M.; Zaid, B. Thumb movement and touch-based interaction heuristics in smart devices: Advances in human and smart device interaction. Int. J. Mob. Hum. Comput. Interact. 2020. [Google Scholar] [CrossRef]
  26. Turin, S. Coronavirus: Qual è il Numero (Vero) di Persone Sottoposte ai Tamponi in Italia. Available online: https://www.corriere.it/salute/malattie_infettive/20_aprile_23/coronavirus-quante-persone-sono-state-sottoposte-tampone-davvero-5bb59814-847c-11ea-8d8e-1dff96ef3536.shtml (accessed on 23 April 2020).
  27. Mumphrey, N. Orleans, Parish Jefferson Testing Sites Expand to Anyone Showing Symptoms of COVID-19. Available online: https://www.fox8live.com/2020/03/21/orleans-jefferson-parish-testing-sites-expand-anyone-showing-symptoms-covid-/ (accessed on 8 May 2020).
  28. Coronavirus Testing: How it is Done, When You Should Get one and How Long Results Take. Available online: https://www.liverpoolecho.co.uk/news/uk-world-news/coronavirus-testing-how-done-you-17912266 (accessed on 27 April 2020).
  29. Gray, N.; Calleja, D.; Wimbush, A.; Miralles-Dolz, E.; Gray, A.; De-Angelis, M.; Derrer-Merk, E.; Uchenna-Oparaji, B.; Stepanov, V.; Clearkin, L.; et al. No test is better than a bad test: Impact of diagnostic uncertainty in mass testing on the spread of Covid-19. medRxiv 2020. [Google Scholar] [CrossRef]
  30. Szklarsky, C. False Positive COVID-19 Test Results Rare Despite Recent Scares, Experts Say. Available online: https://www.ctvnews.ca/health/coronavirus/false-positive-covid-19-test-results-rare-despite-recent-scares-experts-say-1.4932859/ (accessed on 10 May 2020).
  31. Eberhardt, J.N.; Breuckmann, N.P.; Eberhardt, C.S. Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening. J. Clin. Virol. 2020. [Google Scholar] [CrossRef]
  32. Ng, G.; Wang, C. The Proportion Testing Positive for SARS-COV-2 among the Tested Population in the U.S.: Benefits of the Positive Test ratio under Scaled Testing Scenarios. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
  33. Corman, V.M.; Landt, O.; Kaiser, M.; Molenkamp, R.; Meijer, A.; Chu, D.K.W.; Bleicker, T.; Brünink, S.; Schneider, J.; Schmidt, M.L.; et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 2020. [Google Scholar] [CrossRef] [Green Version]
  34. Martinez-Garcia, M.; Zhang, Y.E.; Suzuki, K.; Zhang, Y.-D. Deep Recurrent Entropy Adaptive Model for System Reliability Monitoring. IEEE Trans. Ind. Inform. 2020, 1. [Google Scholar] [CrossRef]
  35. Martinez-Garcia, M.; Zhang, Y.; Wan, J.; McGinty, J. Visually interpretable profile extraction with an autoencoder for health monitoring of industrial systems. In Proceedings of the 2019 4th IEEE International Conference on Advanced Robotics and Mechatronics, ICARM 2019, Toyonaka, Japan, 3–5 July 2019. [Google Scholar]
  36. 2020 Coronavirus Pandemic in Italy. Available online: https://en.wikipedia.org/wiki/2020_coronavirus_pandemic_in_Italy#cite_note-139 (accessed on 29 April 2020).
  37. Veneto. Available online: https://en.wikipedia.org/wiki/File:Map_of_region_of_Veneto,_Italy,_with_provinces-en.svg (accessed on 29 April 2020).
  38. Coronavirus, la Situazione in Italia. Available online: https://lab.gedidigital.it/gedi-visual/2020/coronavirus-i-contagi-in-italia/ (accessed on 29 April 2020).
  39. AdminStat Maps, Analysis and Statistics about the Resident Population. Available online: https://ugeo.urbistat.com/AdminStat/en/it/demografia/dati-sintesi/milano/15/3 (accessed on 2 May 2020).
  40. World Population Review. Available online: http://worldpopulationreview.com/countries/ (accessed on 29 April 2020).
  41. Jafari Petrudi, S.H.; Pirouz, M.; Pirouz, B. Application of fuzzy logic for performance evaluation of academic students. In Proceedings of the 13th Iranian Conference on Fuzzy Systems, IFSC 2013, Qazvin, Iran, 27–29 August 2013. [Google Scholar] [CrossRef]
  42. Pirouz, B.; Khorram, E. A computational approach based on the \epsilon-constraint method in multi-objective optimization problems. Adv. Appl. Stat. 2016. [Google Scholar] [CrossRef]
  43. Pirouz, B.; Ramezani Paschapari, J. A Computational Algorithm Based on Normalization for Constructing the Pareto Front of Multiobjective Optimization Problems. In Proceedings of the 5th International Conference on Industrial and Systems Engineering, Mashhad, Iran, 4–5 September 2019. [Google Scholar]
  44. Palermo, S.A.; Talarico, V.C.; Turco, M. On the LID systems effectiveness for urban stormwater management: Case study in Southern Italy. IOP Conf. Ser. Earth Environ. Sci. 2020, 410, 012012. [Google Scholar] [CrossRef]
  45. Palermo, S.A.; Zischg, J.; Sitzenfrei, R.; Rauch, W.; Piro, P. Parameter Sensitivity of a Microscale Hydrodynamic Model. In Proceedings of the International Conference on Urban Drainage Modelling, Palermo, Italy, 23–26 September 2018; pp. 982–987. [Google Scholar]
  46. Palermo, S.A.; Talarico, V.C.; Pirouz, B. Optimizing Rainwater Harvesting Systems for Non-potable Water Uses and Surface Runoff Mitigation. In Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics); Springer: Cham, Switzerland, 2020. [Google Scholar] [CrossRef]
  47. Pirouz, B.; Palermo, S.A.; Turco, M.; Piro, P. New Mathematical Optimization Approaches for LID Systems. In Proceedings of the International Conference on Numerical Computations: Theory and Algorithms, Crotone, Italy, 15–21 June 2019. [Google Scholar] [CrossRef]
  48. Oberascher, M.; Zischg, J.; Palermo, S.A.; Kinzel, C.; Rauch, W.; Sitzenfrei, R. Smart Rain Barrels: Advanced LID Management Through Measurement and Control. In Proceedings of the International Conference on Urban Drainage Modelling, Palermo, Italy, 23–26 September 2018. [Google Scholar]
  49. AdiSrikanth; Kulkarni, N.J.; Naveen, K.V.; Singh, P.; Srivastava, P.R. Test case optimization using artificial bee colony algorithm. In Proceedings of the International Conference on Advances in Computing and Communications, Kochi Kerala, India, 22–24 July 2011. [Google Scholar]
  50. Cox, P.T.; Song, B. A formal model for component-based software. In Proceedings of the 2001 IEEE Symposium on Human-Centric Computing, Stresa, Italy, 5–7 September 2001. [Google Scholar]
  51. Zhu, G.; Kwong, S. Gbest-guided artificial bee colony algorithm for numerical function optimization. Appl. Math. Comput. 2010. [Google Scholar] [CrossRef]
  52. Li, J.; Pan, Q.; Xie, S. Flexible job shop scheduling problems by a hybrid artificial bee colony algorithm. In Proceedings of the 2011 IEEE Congress of Evolutionary Computation, CEC 2011, New Orleans, LA, USA, 5–8 June 2011. [Google Scholar]
  53. Windisch, A.; Wappler, S.; Wegener, J. Applying particle swarm optimization to software testing. In Proceedings of the GECCO 2007: Genetic and Evolutionary Computation Conference, London, UK, 7–11 July 2007. [Google Scholar]
  54. Ahmed, B.S.; Zamli, K.Z. A greedy particle swarm optimization strategy for T-way software testing. J. Artif. Intell. 2012. [Google Scholar] [CrossRef] [Green Version]
  55. Krause, J.; Cordeiro, J.; Parpinelli, R.S.; Lopes, H.S.A. A Survey of Swarm Algorithms Applied to Discrete Optimization Problems. In Swarm Intelligence and Bio-Inspired Computation; Elsevier: Amsterdam, The Netherlands, 2013. [Google Scholar]
  56. Durante, M.; Orecchia, R.; Loeffler, J.S. Charged-particle therapy in cancer: Clinical uses and future perspectives. Nat. Rev. Clin. Oncol. 2017, 14, 483–495. [Google Scholar] [CrossRef]
  57. Gu, W.; O’Connor, D.; Nguyen, D.; Yu, V.Y.; Ruan, D.; Dong, L.; Sheng, K. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors. Med. Phys. 2018. [Google Scholar] [CrossRef]
  58. Emma, A.; Maurizio, A.; Alessio, L.; Francesca, M.; Filippo, M.; Pietro, P.; Giuseppe, P.; Fabrizio, R.; Giorgio, R.; Marco, S.; et al. Combinatorial optimisation in radiotherapy treatment planning. AIMS Med. Sci. 2018, 5, 2014–2223. [Google Scholar]
  59. Owen, H.; Lomax, A.; Jolly, S. Current and future accelerator technologies for charged particle therapy. Nucl. Instrum. Methods Phys. Res. Sect. A Accel. Spectrometers Detect. Assoc. Equip. 2016. [Google Scholar] [CrossRef] [Green Version]
  60. Robini, M.C.; Yang, F.; Zhu, Y. A stochastic approach to full inverse treatment planning for charged-particle therapy. J. Glob. Optim. 2020. [Google Scholar] [CrossRef]
  61. Palermo, S.A.; Turco, M.; Principato, F.; Piro, P. Hydrological effectiveness of an extensive green roof in Mediterranean climate. Water 2019, 11, 1378. [Google Scholar] [CrossRef] [Green Version]
  62. Myers, J.L.; Well, A.D. Research Design and Statistical Analysis; Routledge: London, UK, 2010. [Google Scholar]
  63. Gupta, P.; Sinha, N.K. Neural Networks for Identification of Nonlinear Systems: An Overview. In Soft Computing and Intelligent Systems; Academic Press: San Diego, CA, USA, 2000; Available online: https://0-doi-org.brum.beds.ac.uk/10.1016/B978-012646490-0/50017-2 (accessed on 21 September 2020).
  64. Arulampalam, G.; Bouzerdoum, A. A generalized feedforward neural network architecture for classification and regression. Neural Netw. 2003, 16, 561–568. [Google Scholar] [CrossRef]
  65. Bouzerdoum, A.; Mueller, R. A generalized feedforward neural network architecture and its training using two stochastic search methods. Lect. Notes Comput. Sci. 2003. [Google Scholar] [CrossRef]
  66. Meyer-Baese, A.; Schmid, V. Foundations of Neural Networks. In Pattern Recognition and Signal Analysis in Medical Imaging; Elsevier: Amsterdam, The Netherlands, 2014. [Google Scholar]
  67. Patterson, J.; Gibson, A. Deep Learning: A Practionar Approach; O’Reilly Media, Inc.: Sevastopol, CA, USA, 2017. [Google Scholar]
  68. Prin, M.; Wunsch, H. International comparisons of intensive care: Informing outcomes and improving standards. Curr. Opin. Crit. Care 2012, 18, 700–706. [Google Scholar] [CrossRef] [Green Version]
  69. Rhodes, A.; Moreno, R. Intensive care provision: A global problem. Rev. Bras. Ter. Intensiva 2012, 24, 322–325. [Google Scholar] [CrossRef] [Green Version]
  70. Perugini, E. La Situazione dei Posti di Terapia Intensiva in Italia. Available online: https://www.agi.it/cronaca/news/2020-03-14/coronavirus-posti-terapia-intensiva-7530891/ (accessed on 14 May 2020).
  71. The Countries Critical with the Most Critical Care Beds per Capital. Available online: https://specials-images.forbesimg.com/imageserve/5e6a0fadaa5428000759a47e/960x0.jpg?fit=scale (accessed on 14 May 2020).
Figure 1. The analysis flowchart.
Figure 1. The analysis flowchart.
Information 11 00454 g001
Figure 2. Location of the selected case studies [36,37,38].
Figure 2. Location of the selected case studies [36,37,38].
Information 11 00454 g002
Figure 3. Daily variations of the parameters in the whole of Italy.
Figure 3. Daily variations of the parameters in the whole of Italy.
Information 11 00454 g003
Figure 4. Daily tests and total positive cases in the whole of Italy.
Figure 4. Daily tests and total positive cases in the whole of Italy.
Information 11 00454 g004
Figure 5. The best cost per iteration via the ANN-GFFN algorithm.
Figure 5. The best cost per iteration via the ANN-GFFN algorithm.
Information 11 00454 g005
Figure 6. Predicted values by the ANN algorithm vs. testing dataset.
Figure 6. Predicted values by the ANN algorithm vs. testing dataset.
Information 11 00454 g006
Figure 7. The impact of each variable on the result (Intensive care hospital), based on the training dataset.
Figure 7. The impact of each variable on the result (Intensive care hospital), based on the training dataset.
Information 11 00454 g007
Table 1. The selected case studies in Italy [39,40].
Table 1. The selected case studies in Italy [39,40].
Region/CountryCapitalPopulationAvailable Dataset
LombardyMilan10,040,0001 March to 30 April
VenetoVenice4,906,0001 March to 30 April
PiedmontTurin4,356,0006 March to 30 April
Emilia–RomagnaBologna4,459,0006 March to 30 April
CampaniaNaples5,827,0007 March to 30 April
SicilyPalermo5,000,0008 March to 30 April
ItalyRome60,317,1161 March to 30 April
Table 2. T-test results for two periods for the whole of Italy.
Table 2. T-test results for two periods for the whole of Italy.
Case StudyVariablesDateAverageRate of Changet-TestResult
t Valuep-Value
All ItalyTest No.1 March–31 March15,7523.12−11.1290.000Significant difference
1 April–30 April49,075
Home isolation1 March–31 March15,7684.57−16.5130.000
1 April–30 April72,053
Mild hosp.1 March–31 March12,7632.00−6.8580.000
1 April–30 April25,566
Int care hosp.1 March–31 March19861.49−3.4570.000
1 April–30 April2975
Daily Deaths1 March–31 March4001.29−1.9010.062No significant difference
1 April–30 April518
Daily new cases1 March–31 March33760.980.1310.896
1 April–30 April3322
Table 3. Test No. (Independent variable) vs. each outcome variable within two time periods (All Italy).
Table 3. Test No. (Independent variable) vs. each outcome variable within two time periods (All Italy).
CountryPeriodDependent VariableANOVA p-ValueBetaExistence of a CorrelationSignificance
All Italy1 March–31 MarchHome isolation0.0000.896Positive
Mild hosp.0.0000.928
Int. care hosp.0.0000.931
Daily Deaths0.0000.946
Daily new cases0.0000.921
1 April–30 AprilHome isolation0.0000.616
Mild hosp.0.001−0.591Negative
Int. care hosp.0.000−0.636
Daily Deaths0.004−0.509
Daily new cases0.115−0.294×- *
* There is no significant relationship between the variables.
Table 4. T-test results within two periods (Lombardy, Veneto, and Piedmont).
Table 4. T-test results within two periods (Lombardy, Veneto, and Piedmont).
RegionVariablePeriodAverageRate of Changet-TestResult
t Valuep-Value
LombardyTest No.1 March–31 March35252.48−8.1850.000Significant difference
1 April–30 April8743
Home isolation1 March–31 March50064.06−12.6350.000
1 April–30 April20,335
Mild hosp.1 March–31 March60871.72−5.6220.000
1 April–30 April10,483
Int care hosp.1 March–31 March7911.30−2.6250.011
1 April–30 April1025
Daily Deaths1 March–31 March2310.940.3510.727No significant difference
1 April–30 April219
Daily new cases1 March–31 March13740.791.9640.057
1 April–30 April1084
VenetoTest No. 1 March–30 March30432.64−9.1060.000Significant difference
31 March–30 April8041
Home isolation1 March–30 March20413.97−16.4520.000
31 March–30 April8102
Mild hosp.1 March–30 March6642.09−6.5200.000
31 March–30 April1386
Int care hosp.1 March–30 March1641.37−2.2590.027
31 March–30 April225
Daily Deaths1 March–30 March142.466.6210.000
31 March–30 April34
Daily new cases1 March–30 March2851.05−0.3160.752No significant difference
31 March–30 April298
PiedmontTest No. 6 March–6 April12683.69−10.5190.000Significant difference
7 April–30 April4684
Home isolation6 March–6 April21464.84−14.7300.000
7 April–30 April10,378
Mild hosp.6 March–6 April18941.68−5.7290.000
7 April–30 April3180
Int care hosp.6 March–6 April2821.10−0.9610.381No significant difference
7 April–30 April312
Daily Deaths6 March–6 April391.94−6.1110.000Significant difference
7 April–30 April76
Daily new cases6 March–6 April4000.792.8520.005
7 April–30 April561
Table 5. Test No. (Independent variable) vs. each outcome variable within two time periods (Lombardy, Veneto, and Piedmont).
Table 5. Test No. (Independent variable) vs. each outcome variable within two time periods (Lombardy, Veneto, and Piedmont).
RegionDateDependent VariableANOVA p-ValueBetaExistence of a CorrelationSign
Lombardy1 March–31 MarchHome isolation0.0000.683Positive
Mild hosp.0.0000.665
Int. care hosp.0.0000.690
Daily Deaths0.0000.782
Daily new cases0.0000.856
1 April–30 AprilHome isolation0.0040.515
Mild hosp.0.004−0.506Negative
Int. care hosp.0.002−0.552
Daily Deaths0.005−0.497
Daily new cases0.693−0.075×- *
Veneto1 March–30 MarchHome isolation0.0000.772Positive
Mild hosp.0.0000.782
Int. care hosp.0.0000.795
Daily Deaths0.0000.715
Daily new cases0.0000.758
31 March–30 AprilHome isolation0.2270.223×- *
Mild hosp.0.036−0.379Negative
Int. care hosp.0.032−0.386
Daily Deaths0.604−0.097×- *
Daily new cases0.864−0.032×- *
Piedmont6 March–6 AprilHome isolation0.0000.835Positive
Mild hosp.0.0000.882
Int. care hosp.0.0000.863
Daily Deaths0.0000.825
Daily new cases0.0000.857
7 April–30 AprilHome isolation0.0020.607
Mild hosp.0.005−0.549Negative
Int. care hosp.0.005−0.558
Daily Deaths0.745−0.330×- *
Daily new cases0.250−0.244×-*
* There is no significant relationship between the variables.
Table 6. T-test results within two periods (Emilia–Romagna, Campania, and Sicily).
Table 6. T-test results within two periods (Emilia–Romagna, Campania, and Sicily).
RegionVariablePeriodAverageRate of Changet-TestResult
t Valuep-Value
Emilia RomagnaTest No.6 March–9 April22082.18−7.1300.000Significant difference
10 April–30 April4816
Home isolation6 March–9 April40682.36−10.2340.000
10 April–30 April9591
Mild hosp.6 March–9 April23441.30−2.9170.005
10 April–30 April3053
Int care hosp.6 March–9 April2411.19−2.1150.039
10 April–30 April285
Daily Deaths6 March–9 April620.950.5160.608No significant difference
10 April–30 April59
Daily new cases6 March–9 April2440.363.8700.000Significant difference
10 April–30 April87
CampaniaTest No. 7 March–1 April5873.55−10.5660.000
2 April–30 April2082
Home isolation7 March–1 April4654.79−20.8190.000
2 April–30 April2229
Mild hosp.7 March–1 April2242.53−9.7340.005
2 April–30 April568
Int care hosp.7 March–1 April671.10−0.5870.561No significant difference
2 April–30 April74
Daily Deaths7 March–1 April61.27−1.0700.290
2 April–30 April7
Daily new cases7 March–1 April840.790.2950.769
2 April–30 April79
SicilyTest No. 8 March–4 April6703.43−7.9900.000Significant difference
5 April–30 April2299
Home isolation8 March–4 April4283.59−13.5520.000
5 April–30 April1534
Mild hosp.8 March–4 April2402.13−7.1010.000
5 April–30 April511
Int care hosp.8 March–4 April441.08−0.6000.552No significant difference
5 April–30 April47
Daily Deaths8 March–4 April41.20−0.8260.413
5 April–30 April5
Daily new cases8 March–4 April680.692.2680.030Significant difference
5 April–30 April47
Table 7. Test No. (Independent variable) vs. outcome variables within two periods (Emilia–Romagna, Campania, and Sicily).
Table 7. Test No. (Independent variable) vs. outcome variables within two periods (Emilia–Romagna, Campania, and Sicily).
RegionPeriodDependent VariableANOVA p-ValueBetaExistence of a CorrelationSignificance
Emilia Romagna6 March–9 AprilHome isolation0.0000.576positive
Mild hosp0.0000.659
Int. care hosp0.0000.658
Daily Deaths0.0000.646
Daily new cases0.0000.717
10 April–30 AprilHome isolation0.141−0.332×- *
Mild hosp0.075−0.397×- *
Int. care hosp0.097−0.372×- *
Daily Deaths0.282−0.246×- *
Daily new cases0.975−0.007×- *
Campania7 March–1 AprilHome isolation0.0000.876positive
Mild hosp0.0000.933
Int. care hosp0.0000.792
Daily Deaths0.0000.751
Daily new cases0.0000.859
2 April–30 AprilHome isolation0.1720.261×- *
Mild hosp0.014−0.453negative
Int. care hosp0.002−0.543
Daily Deaths0.002−0.556
Daily new cases0.014−0.453
Sicily8 March–4 AprilHome isolation0.0000.780positive
Mild hosp0.0000.810
Int. care hosp0.0000.842×- *
Daily Deaths0.0000.883positive
Daily new cases0.0000.734
5 April–30 AprilHome isolation0.0120.485
Mild hosp0.071−0.360×- *
Int. care hosp0.036−0.413negative
Daily Deaths0.714−0.076×- *
Daily new cases0.7440.067×- *
* There is no significant relationship between the variables.
Table 8. Details of the developed model of ANN-GFN.
Table 8. Details of the developed model of ANN-GFN.
Control ParametersValues
Number of hidden layers5
Maximum number of iterations100
Number of training data 43 (70%)
Number of cross-validation data9 (15%)
Number of testing data9 (15%)
Input processing elements (PEs)3
Output processing elements (PEs)1
Table 9. The results of the ANN model.
Table 9. The results of the ANN model.
FactorsTraining ValueValidation ValueTest Value
MSE (mean squared error)25,910.65229,293.51917,537.786
R20.9820.9880.990
Min Abs Error6.40082.6264.350
Max Abs Error320.300289.164227.142
For all data R2 = 0.987.
Table 10. Critical care units in different countries (per 100,000 inhabitants) [71].
Table 10. Critical care units in different countries (per 100,000 inhabitants) [71].
CountriesCritical Care Units
United States34.7
Germany29.2
Italy12.5
France11.6
South Korea10.6
Spain9.7
Japan7.3
United Kingdom6.6
China3.6
India2.3
Table 11. The results of the MLR analysis.
Table 11. The results of the MLR analysis.
Variablesp-ValueBetaCoefficients
Constant0.011-77.751
Total home isolation (x1)0.000−0.514−0.020
Total mild hospital (x2)0.0001.3110.164
Daily new cases (x3)0.0090.0500.38

Share and Cite

MDPI and ACS Style

Pirouz, B.; Nejad, H.J.; Violini, G.; Pirouz, B. The Role of Artificial Intelligence, MLR and Statistical Analysis in Investigations about the Correlation of Swab Tests and Stress on Health Care Systems by COVID-19. Information 2020, 11, 454. https://0-doi-org.brum.beds.ac.uk/10.3390/info11090454

AMA Style

Pirouz B, Nejad HJ, Violini G, Pirouz B. The Role of Artificial Intelligence, MLR and Statistical Analysis in Investigations about the Correlation of Swab Tests and Stress on Health Care Systems by COVID-19. Information. 2020; 11(9):454. https://0-doi-org.brum.beds.ac.uk/10.3390/info11090454

Chicago/Turabian Style

Pirouz, Behzad, Hana Javadi Nejad, Galileo Violini, and Behrouz Pirouz. 2020. "The Role of Artificial Intelligence, MLR and Statistical Analysis in Investigations about the Correlation of Swab Tests and Stress on Health Care Systems by COVID-19" Information 11, no. 9: 454. https://0-doi-org.brum.beds.ac.uk/10.3390/info11090454

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop